DOXORUBICINOL - A MORE POTENT CARDIOTOXIN THAN DOXORUBICIN

被引:0
|
作者
OLSON, RD
BRENNER, DE
MUSHLIN, PS
BOERTH, RC
HANDE, KR
BOUCEK, RJ
机构
[1] UNIV S ALABAMA,MOBILE,AL 36688
[2] UNIV WASHINGTON,SEATTLE,WA 98195
[3] VET ADM MED CTR,BOISE,ID
[4] VET ADM MED CTR,NASHVILLE,TN 37203
[5] VANDERBILT UNIV,NASHVILLE,TN 37240
来源
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:227 / 227
页数:1
相关论文
共 50 条
  • [1] DOXORUBICINOL, THE METABOLITE OF DOXORUBUCIN, IS MORE CARDIOTOXIC THAN DOXORUBICIN
    BOUCEK, RJ
    KUNKEL, EM
    GRAHAM, TP
    BRENNER, D
    OLSON, RD
    PEDIATRIC RESEARCH, 1987, 21 (04) : A187 - A187
  • [2] DOXORUBICINOL - THE CULPRIT IN DOXORUBICIN CARDIOTOXICITY
    MUSHLIN, PS
    BOUCEK, RJ
    BRENNER, DE
    CUSACK, BJ
    FLEISCHER, S
    OLSON, RD
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 195 - 195
  • [3] Analysis of doxorubicin and doxorubicinol in rat myocardia
    Anderson, M. Jennifer
    Karnilaw, Peter
    Jensen, M. S. Brock
    Hayward, Reid
    Hyslop, Richard M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [4] Formamidinodoxorubicins Are more Potent than Doxorubicin as Apoptosis Inducers in Human Breast Cancer Cells
    Marczak, Agnieszka
    Denel-Bobrowska, Marta
    Lukawska, Malgorzata
    Oszczapowicz, Irena
    ANTICANCER RESEARCH, 2015, 35 (04) : 1935 - 1940
  • [5] THE EFFECT OF PHENYTOIN ON DOXORUBICIN AND DOXORUBICINOL PHARMACOKINETICS
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CLINICAL RESEARCH, 1988, 36 (01): : A117 - A117
  • [6] More potent than cisplatin
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (02): : 156 - +
  • [7] TISSUE DISTRIBUTION OF DOXORUBICIN AND DOXORUBICINOL IN RATS RECEIVING MULTIPLE DOSES OF DOXORUBICIN
    PETERS, JH
    GORDON, GR
    KASHIWASE, D
    ACTON, EM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 7 (01) : 65 - 69
  • [8] EFFECT OF PHENYTOIN ON DOXORUBICIN AND DOXORUBICINOL PHARMACOKINETICS IN THE RABBIT
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CLINICAL RESEARCH, 1988, 36 (03): : A362 - A362
  • [9] EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF DOXORUBICIN AND DOXORUBICINOL IN THE RABBIT
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (04) : 294 - 298
  • [10] DOXORUBICIN CARDIOTOXICITY MAY BE CAUSED BY ITS METABOLITE, DOXORUBICINOL
    OLSON, RD
    MUSHLIN, PS
    BRENNER, DE
    FLEISCHER, S
    CUSACK, BJ
    CHANG, BK
    BOUCEK, RJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) : 3585 - 3589